Forodesine hydrochloride: Phase I preliminary data

Preliminary data from an open-label, dose-escalating Phase I trial in

Read the full 105 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE